Latest Sales Growth News

OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Mirvac Group reported robust operational results in 3Q26, driven by a 28% jump in residential sales, high occupancy across its investment portfolio, and a successful $630 million capital raise for its wholesale office fund. The company reaffirmed its FY26 guidance amid cautious risk management.

Scentre Group has initiated a tender offer to repurchase all of its US$1.312 billion Non-Call 2030 Subordinated Notes, aiming to refinance this debt through existing senior bank facilities. The move follows recent capital management efforts and sets the stage for updated debt metrics.

Scentre Group’s first-quarter update reveals robust sales and visitation gains, near-full occupancy, and steady capital management moves, underpinning its confidence in 2026 earnings growth despite geopolitical uncertainties.

Scentre Group's first quarter update reveals robust retail sales growth and strong leasing metrics, alongside significant capital management moves including bond redemption and a major joint venture stake sale.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Lark Distilling Co. edged up net sales to $4.3 million in Q3 FY26, buoyed by growth in travel retail and B2B channels, while unveiling its new Signature Whisky Range that snagged top design honours.

Challenger Limited reported a 19% jump in Life sales to $1.7 billion in Q3 FY26, driven by strong annuity demand and offshore growth. Despite a 10% dip in Funds Management FUM amid market volatility, the company advanced key retirement partnerships and tightened its FY26 EPS guidance.

MyEco Group has locked in $0.92 million through its Series 2 convertible note program, reinforcing its growth trajectory with funding earmarked for a new GRS-certified recycled bin liner range. The raise supplements a solid cash position while aiming to limit shareholder dilution amid challenging market conditions.

Immuron Limited’s unaudited Q3 FY26 sales rose 16% to AUD 1.5 million, driven by Travelan’s expanding footprint in Australia, Canada, and the US despite a stronger Australian dollar.